Suchergebnisse - (Subject:"Siltuximab")

PubPharm (96)

1

Castleman's disease, pathophysiology, advances in diagnosis and treatment

enthalten in: Medicina clinica | 2024

von Pertusa Mataix, R. | Loaiza Cabello, D. | García Morillo, J.

2

Siltuximab administration results in spurious IL-6 elevation in peripheral blood

enthalten in: American journal of hematology | 2024

von Mango, N. | Pierson, S. | Sarmiento Bustamante, M. | +3

3

Therapy of Castleman's disease with siltuximab - case report and review of literature

enthalten in: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti | 2023

von Adam, Z. | Zeman, D. | Chodacki, A. | +8

4

The role of interleukin 6 in the pathogenesis and therapy of Castleman disease - an immunologist's perspective

enthalten in: Casopis lekaru ceskych | 2023

von Milota, T. | Střížová, Z. | Sobotková, M. | +1

5

HNRNPC downregulation inhibits IL-6/STAT3-mediated HCC metastasis by decreasing HIF1A expression

enthalten in: Cancer science | 2022

von Liu, D. | Luo, X. | Xie, M. | +11

6

A New Approach to the Management of COVID-19. Antagonists of IL-6 : Siltuximab

enthalten in: Advances in therapy | 2022

von Villaescusa, L. | Zaragozá, F. | Gayo-Abeleira, I. | +1

7

Advances in clinical outcomes : What we have learned during the COVID-19 pandemic

enthalten in: The Journal of allergy and clinical immunology | 2022

von Al-Musa, A. | LaBere, B. | Habiballah, S. | +2

8

A New Approach to the Management of COVID-19. Antagonists of IL-6: Siltuximab

enthalten in: Advances in therapy | 2022

von Villaescusa, L. | Zaragozá, F. | Gayo-Abeleira, I. | +1

9

A New Approach to the Management of COVID-19. Antagonists of IL-6: Siltuximab

enthalten in: Advances in therapy | 2022

von Villaescusa, L. | Zaragozá, F. | Gayo-Abeleira, I. | +1

10

A New Approach to the Management of COVID-19. Antagonists of IL-6: Siltuximab

enthalten in: Advances in therapy | 2022

von Villaescusa, L. | Zaragozá, F. | Gayo-Abeleira, I. | +1

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]